EcoDrugPlus

Ensembl ID : ENSCCRG00000075770
Gene Symbol: -
Cross references: -
263 Possible Orthologues:

Ensembl ID : ENSCCRG00000075377
Gene Symbol: -
Cross references: -
145 Possible Orthologues:

Ensembl ID : ENSCCRG00000075791
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSCCRG00000075926
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSCCRG00000078964
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSCCRG00000079226
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSCCRG00000078910
Gene Symbol: -
Cross references: -
112 Possible Orthologues:

Ensembl ID : ENSCCRG00000074662
Gene Symbol: -
Cross references: -
154 Possible Orthologues:

Ensembl ID : ENSCCRG00000081443
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSCCRG00000081600
Gene Symbol: -
Cross references: -
271 Possible Orthologues:

Ensembl ID : ENSCCRG00000082737
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSCCRG00000072574
Gene Symbol: -
Cross references: -
184 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).